Tirzepatide-Hormone Therapy Combo Tied to Weight Loss in Postmenopausal Women

(MedPage Today) — ORLANDO — Postmenopausal women using hormone therapy (HT) saw significantly greater weight loss while taking the dual GIP/GLP-1 receptor agonist tirzepatide than their counterparts not using HT, according to a retrospective…